Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid drug rebate bill (HR 2890)

Executive Summary

Passes House by voice vote Sept. 22. The measure would amend OBRA '90 by exempting discount prices offered by drug manufacturers to the Veterans Affairs Department, Defense Department, PHS-funded clinics and other government purchasers from Medicaid rebate calculations. It also would guarantee that such purchasers can buy pharmaceuticals at prices at least as low as those obtained by Medicaid, and ensure that prices to V-A are at least 24% lower than those paid by wholesalers for products resold to retail pharmacies. In addition, the bill would raise minimum rebates for Medicaid from 15% to 15.7% in 1993, 15.4% in 1994, 15.2% in 1995 and 15.1% in 1996.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021532

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel